# Molecular Partners AG (MOLN): MoatMap facts

As of 13 Nov 2026. Research data, not investment advice.

As of 13 Nov 2026, the MoatMap Score for Molecular Partners AG (MOLN) is 17/100, ranked against 25,000+ stocks in 38 markets (Quality 21, Value 31, Momentum 46, each scored against its sector).

- MoatMap Score: 17/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 21, Value 31, Momentum 46: each a 0-100 percentile within Healthcare.
- Position: #22,094 overall, #1,998 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 3.01 USD on 12 Nov 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/MOLN
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker